Scope: Fifteen Regulated Activities

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Article 2 of Acuerdo No. 0631-ARSA-2023, the Reglamento para el Control Sanitario de Dispositivos Médicos y otros Dispositivos de Interés Sanitario, defines the scope of application as being of general interest and covers natural or legal persons engaged in 15 categories of activities (whether public or private): manufacture, upgrading (repotenciación), repair, repackaging (acondicionamiento), import, export, storage, transport, distribution, rental (alquiler), lending (comodato), sale, research, advertising, and maintenance services, together with any other related activity; it also covers the technovigilance activities carried out by ARSA. Article 33 separately lists import, repackaging, export, repair, storage, transport, distribution, sale, rental, lending and advertising, 11 categories in all, as acts that require a valid sanitary authorisation first.

  • Article 2 governs persons and Article 33 governs acts; read together, they mean that exporters and repairers also need authorisation.
  • Rental and lending are regulated acts, so free placements, loaners and trial units fall within the authorisation regime.
  • Advertising requires prior authorisation, and Article 77 adds 7 controls and 4 prohibitions for publicity.
  • The closing phrase of Article 2, y/o cualquier otra actividad relacionada, is an open backstop that lets ARSA bring new business models into scope.

2. Legal basis

The following provisions govern the scope of application and the requirement of prior authorisation.

RegulationAcuerdo No. 0631-ARSA-2023, Reglamento para el Control Sanitario de Dispositivos Médicos y otros Dispositivos de Interés SanitarioArticle 2Scope of application: natural or legal persons engaged in 15 categories of activities, whether public or private; also covers the technovigilance activities of ARSA.
RegulationAcuerdo No. 0631-ARSA-2023, Reglamento para el Control Sanitario de Dispositivos Médicos y otros Dispositivos de Interés SanitarioArticle 33Import, repackaging, export, repair, storage, transport, distribution, sale, rental, lending and advertising, 11 categories of acts, require a valid sanitary authorisation first.
RegulationAcuerdo No. 0631-ARSA-2023, Reglamento para el Control Sanitario de Dispositivos Médicos y otros Dispositivos de Interés SanitarioArticle 34Persons without ARSA authorisation are prohibited from performing all of the above acts.
RegulationAcuerdo No. 0631-ARSA-2023, Reglamento para el Control Sanitario de Dispositivos Médicos y otros Dispositivos de Interés SanitarioArticle 513 control instruments: licensing, risk classification, sanitary registration, registration exemption, special import authorisation, special donation authorisation, NTDM, RUIF, and 5 categories of good practice certificates.
RegulationAcuerdo No. 0631-ARSA-2023, Reglamento para el Control Sanitario de Dispositivos Médicos y otros Dispositivos de Interés SanitarioArticle 7Establishments apply the good practices BPM, BPAC, BPAD, BPC, BPT and BPL according to their nature.
RegulationAcuerdo No. 0631-ARSA-2023, Reglamento para el Control Sanitario de Dispositivos Médicos y otros Dispositivos de Interés SanitarioArticle 2The scope is worded as y/o cualquier otra actividad relacionada, leaving an interface for ARSA to extend regulation.

3. Expert insights

Insight 1: Article 2 governs persons and Article 33 governs acts, and the two must be read together. Traders that only export often assume that export requires no registration, but Article 33 expressly lists exportación among the acts requiring prior authorisation, and Article 34 attaches a prohibition to all of them. For Honduran entities handling transit and re-export, this is a direct compliance point.

Insight 2: rental and lending are listed separately. Article 33 names alquiler (rental) and comodato (lending) side by side as regulated acts. This has a large effect on placement models: free placements, rental placements and trial placements all fall within the authorisation regime, and there is no space in which a placement is not a sale merely because no money changes hands. Placement agreements and the scope of the authorisation must be designed together.

Insight 3: advertising is an act requiring prior authorisation. The last item of Article 33 is publicidad, and Article 77 adds 7 controls and 4 prohibitions for advertising. The practical meaning is that an unregistered product cannot even run warm-up publicity, and promotional content must not exceed the scope of the authorisation or the indication information submitted by the registration holder. Marketing schedules must be bound to the registration timetable.

Insight 4: the phrase y/o cualquier otra actividad relacionada is an open backstop. Article 2 adds this sentence after the 15 listed activities, leaving an interface for ARSA to bring new business models into regulation. The effect for companies is that when a new form of business appears, for example remote servicing or devices as a service, it cannot be presumed unregulated merely because it is not in the list; the first step is to request a classification certificate under Article 28.

Insight 5: technovigilance activity itself is within the scope of application. The final sentence of Article 2 brings the technovigilance activities of ARSA into scope, in line with Articles 78 and 79. This explains why vigilance duties could be regulated by a separate ARSA instrument (Acuerdo No. 0185-ARSA-2025): its normative basis is granted by the same main regulation, so no higher law needed to be found.

4. Practical recommendations

  • Inventory the activities the company actually performs against the 15 categories of Article 2, and use that activity list as the basis for the licence application scope.
  • Bring export and repair operations into authorisation planning; do not exclude them from compliance on the ground that goods only leave the country.
  • For placement operations (rental, lending, trials, loans), confirm before signing agreements that the authorisation covers the relevant acts.
  • Bind marketing schedules to registration progress, and run no form of product publicity before authorisation is granted.
  • When a new business model appears, request a classification certificate under Article 28 first and start operations only after a written conclusion.
  • Match the activity scope of the licence application word for word to the Article 2 list; avoid a vague description such as device-related business.

5. Verification checklist

  • □ The company activity inventory has been completed against the 15 categories of Article 2
  • □ Export and repair operations are included in authorisation planning
  • □ Placement agreements confirm that the authorisation covers rental or lending
  • □ Marketing schedules are bound to registration progress
  • □ New business models have obtained a classification conclusion under Article 28
  • □ The activity scope wording of the licence application matches the Article 2 list

Regulatory information verified as of 2026-10-29.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Honduran market. Our team manages Secretariat of Health (SESAL) registration applications through the regulatory directorate, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail